TP53 and neoplasm: These include traditional blood tumor markers (such as CEA, Cyfra21-1, p53, SCC-Ag and VEGF-C) (Zhang et al., 2015), DNA fragments (Tomita et al., 2007), mRNA (Kashyap et al., 2009), and miRNA (Xue et al., 2024).